Cipla | CIPLA - Current Liabilities

Stock Price
1,203.90
Daily Change
11.50 0.96%
Monthly
-9.14%
Yearly
-13.06%
Q2 Forecast
1,166.41

Cipla reported INR62.97B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Arca Biopharma USD 15.37M 5.59M Dec/2025
aTyr Pharma USD 113.19M 97.51M Dec/2025
Bio Path USD 8.68M 819K Sep/2025
Brainstorm Cell Therapeutics USD 11.01M 1.98M Dec/2025
Capricor Therapeutics USD 35.84M 7.69M Dec/2025
Cara Therapeutics USD 11.04M 362K Sep/2025
Cipla INR 62.97B 8.13B Sep/2025
Dr.Reddys Laboratories INR 158.31B 7.38B Dec/2025
Esperion Therapeutics USD 300.81M 58.22M Dec/2025
Immunic USD 30.08M 2.77M Sep/2025
Infinity Pharmaceuticals USD 12.06M 775K Jun/2023
Minerva Neurosciences USD 2.29M 381K Dec/2025
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Sun Pharmaceuticals INR 234.15B 52.21B Sep/2025
TherapeuticsMD USD 5.82M 655K Jun/2024
UPL INR 330.9B 45.21B Sep/2025